Local researchers have developed a COVID-19 nasal spray vaccine that has proven to be effective in protecting against the Delta variant of SARS-CoV-2 in animal studies, National Taiwan University Hospital (NTUH) said yesterday.
Worldwide cases of COVID-19 infections have reached more than 250 million and more than 7 billion vaccine doses have been administered, but the pandemic does not seem to be coming to an end, said National Taiwan University Children’s Hospital superintendent Huang Li-min (黃立民), head of the research project.
Current vaccines administered through intramuscular injections were developed in response to the original strain of SARS-CoV-2, but new and emerging variants
FIGHTING DELTA: More funding would be needed for the intranasal vaccine to go into clinical trial, said Huang Li-min, head of the NTUH research projectBy Lee I-chia / Staff reporter
Taipei, Aug. 26 (CNA) A new type of COVID-19 nasal spray vaccine Taiwan's researchers are developing have shown more effective than the traditional shot in animal trials, and has a chance to enter human trials in the first half of 2022, a research team from National Taiwan University (NTU) said Wednesday.
COVID-19: Local nasal spray vaccine shows promise, NTU says taipeitimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taipeitimes.com Daily Mail and Mail on Sunday newspapers.